Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Perioperative Point-of-Care Ultrasound (POCUS-RCT)

12 de julho de 2018 atualizado por: Ahmed Hegazy, Lawson Health Research Institute

Perioperative Point-of-Care Ultrasound: A Randomized Controlled Trial

The goal of this study is to assess the impact of perioperative point-of-care ultrasound (POCUS) assessment on patient-important outcomes (e.g. hospital length of stay, length of stay in recovery, mortality etc.) and perioperative patient management strategies, in patients undergoing non-elective non-cardiac surgeries.

Visão geral do estudo

Status

Desconhecido

Condições

Intervenção / Tratamento

Descrição detalhada

Preoperative patients undergoing emergency non-cardiac surgery will be approached for study recruitment and participation. Study participants will be randomized to receive, or not, a preoperative POCUS exam as part of their routine preoperative assessment. Patients randomized to receiving a POCUS exam will undergo a protocolized focused cardiac ultrasound, lung and pleural ultrasound and a gastric volume and content ultrasound assessment. Results of this exam will be disclosed to the anesthesiologist and primary care team. Randomization will be stratified by the presence of any sign(s) of cardiorespiratory failure. Signs of cardiorespiratory failure are defined as: systolic blood pressure <90 mmHg, heart rate>100, respiratory rate >24, Oxygen saturation <90%, requirement of supplemental oxygen or mechanical ventilation, new requirement of loop diuretics in current hospital admission, chest pain, newly diagnosed ECG changes, requirement of vasoactive drugs, signs of pre-renal azotemia (BUN:creatinine ratio >20). Outcome data will be collected prospectively. Investigators performing and interpreting the scan will disclose the results to the care team but will not participate in patient care. Primary and secondary outcome data collection will be performed by an investigator blinded to patient assignment. The primary outcome is post anesthetic care unit length-of-stay. The secondary outcomes are post-randomization hospital length of stay, number of operating room (OR) delays for optimization, alterations in anesthetic management (using a brief anesthesiologist-administered survey), intensiveness of OR management (invasive blood pressure monitoring, central venous pressure monitoring, intraoperative TEE), new peri-operative diuretic use, new intensive care admission rates, mortality during this admission, amount/frequency of postoperative investigations, rates of detection of new pathologies identified by preoperative POCUS exam and the rates of adequately diagnostic POCUS studies.

Tipo de estudo

Intervencional

Inscrição (Antecipado)

100

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

  • Canadá
    • Ontario
      • London, Ontario, Canadá, N6A 5A5
        • Recrutamento
        • London Health Sciences Centre
        • Contato:
          • Ahmed Hegazy, Assist. Prof
          • Número de telefone: 5198604917
          • E-mail: ahegazy@uwo.ca
        • Contato:
        • Subinvestigador:
          • Osama Sefein, Resident
        • Subinvestigador:
          • Kiarash Mohajer, Resident
        • Subinvestigador:
          • Philip Jones, Assoc. Prof
        • Subinvestigador:
          • Ramiro Arellano, Assoc. Prof
        • Subinvestigador:
          • Robert Arntfield, Assist. Prof
        • Subinvestigador:
          • Wilfredo Puentes, Assist. Prof
        • Subinvestigador:
          • Jonathan Borger, Assist. Prof

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

18 anos e mais velhos (Adulto, Adulto mais velho)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

  • Patients aged >17 years
  • Undergoing urgent or emergent non-cardiac surgery classified as intermediate or high risk according to American Heart Association(AHA)/American College of Cardiology(ACC) guidelines.

These include vascular surgeries (supra or infra-inguinal), intraperitoneal surgeries, intra-thoracic surgeries, head and neck surgeries, spine surgeries, urologic surgeries, and proximal extremity orthopedic surgeries. Peripheral extremity surgeries (wrist or below, and ankle or below), in addition to appendectomies and cholecystectomy surgeries will be excluded from this study.

Exclusion Criteria:

  • Patients scheduled for elective or pre-booked surgeries
  • Patients undergoing cardiac surgeries
  • Patients undergoing low risk procedures e.g. endoscopic procedures, superficial skin, subcutaneous tissue, breast, ophthalmic, and ambulatory surgeries
  • Patients undergoing orthopedic peripheral extremity surgeries (e.g. ankle, wrist, hand, foot)
  • Patients who have had an echo during the current hospital admission prior to recruitment.
  • Patients where the investigator performing or over-reading the POCUS scan is required to participate directly in perioperative patient care (e.g. anesthesiologist co-investigator performing or over-reading scan is on-call for this emergency case)

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Diagnóstico
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Solteiro

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Scan group
Patients randomized to the scan group (intervention arm) will receive a preoperative point-of-care ultrasound (POCUS) exam as an adjunct to their preoperative assessment, the results of which will be disclosed to the anesthesiologist and the patient care team. This POCUS exam will include a focused cardiac ultrasound, a lung and pleural ultrasound, and a gastric volume and content ultrasound assessment. Patients randomized to this arm may also receive repeat POCUS exams as needed and as clinical conditions change. These repeat exams may be requested by the anesthesiologist or patient care team.
Teste de diagnostico: Scan
The preoperative point of care ultrasound includes a protocolized focused cardiac ultrasound, lung and pleural ultrasound and a gastric volume and content ultrasound assessment, all of which will be performed as an adjunct to the anesthesiologist's assessment. The result of this ultrasound examination will be disclosed to the anesthesiologist and patient care teams. Repeat ultrasounds may be done as the patient's clinical condition changes, or as requested by the anesthesiologist or patient care team.
Outros nomes:
  • POCUS
  • Exame de ultrassom
  • Ultrassom no local de atendimento
Sem intervenção: No scan group
Patients randomized to no scan (control arm) will not receive a preoperative point-of-care ultrasound exam. Patients in this arm will receive the standard-of-care; a routine preoperative assessment and physical examination by their attending anesthesiologist.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Post-anaesthesia care unit (PACU) length of stay
Prazo: From time of PACU admission until the time of transfer from PACU, assessed up to 48 hours.
Total time (minutes) from postoperative PACU admission to PACU discharge.
From time of PACU admission until the time of transfer from PACU, assessed up to 48 hours.

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Post-randomization hospital length-of-stay
Prazo: From date of randomization until the date of hospital discharge or death from any cause, whichever came first, assessed up to 4 weeks.
Number of days in hospital from study enrollment to discharge or death.
From date of randomization until the date of hospital discharge or death from any cause, whichever came first, assessed up to 4 weeks.
New ICU admission rates
Prazo: From time of randomization to the immediate postoperative period, assessed up to 6 hours after the conclusion of surgery.
New admissions to ICU in the immediate post operative period in patients previously on the ward or in the emergency department.
From time of randomization to the immediate postoperative period, assessed up to 6 hours after the conclusion of surgery.
Rates of detection of unexpected or new pathologies
Prazo: From time of randomization to the time of interpretation of the last POCUS scan, assessed up to 2 weeks from randomization.
New cardiac, pulmonary or gastric pathology detected by preoperative POCUS not known to be present previously. Examples include valve lesions, resting regional wall motion abnormalities, ventricular dysfunction, ventricular hypertrophy, pulmonary edema, consolidation and/or pleural effusion. This will be calculated only for participants randomized to the Scan Group.
From time of randomization to the time of interpretation of the last POCUS scan, assessed up to 2 weeks from randomization.
Change in anesthetic plan based on the scan result
Prazo: From time of randomization to the time of interpretation of the last POCUS scan, assessed up to 2 weeks from randomization.
A survey will be administered to the anesthesiologist caring for the patient asking whether the POCUS exam findings influenced the anesthetic plan for the patient. If the answer is "yes, it did influence the anesthetic plan", subsequent questions will explore how it influenced anesthetic management. These will include questions of whether it influenced fluid management, anesthetic technique, choice of invasive lines, choice or dose of induction agents, or delay of surgery for optimization or further work-up. This will be calculated only in participants randomized to the Scan Group.
From time of randomization to the time of interpretation of the last POCUS scan, assessed up to 2 weeks from randomization.
Intensiveness of operating room (OR) management
Prazo: During OR time post randomization, assessed until the patient is transferred from the OR to PACU, up to 7 days from randomization.
Use of invasive lines i.e. arterial, central lines or TEE monitoring
During OR time post randomization, assessed until the patient is transferred from the OR to PACU, up to 7 days from randomization.
New or change in peri-operative diuretics use
Prazo: From time of enrollment, up to 2 weeks from randomization.
New use or change in pattern of diuretic use in the pre, intra or post operative phases.
From time of enrollment, up to 2 weeks from randomization.
Rates of blood work ordered and imaging investigations
Prazo: From time of enrollment, up to 2 weeks from randomization.
Frequency of post-randomization blood draws, frequency of post-randomization imaging studies (X-rays, CT's, MRI's, ultrasounds, echoes, and nuclear scans).
From time of enrollment, up to 2 weeks from randomization.
Mortality
Prazo: From time of enrollment, up to 4 weeks from randomization.
In-hospital post randomization mortality rate. Patients dying after transfer to another acute care hospital will also be counted as an in-hospital post randomization mortality.
From time of enrollment, up to 4 weeks from randomization.
Rates of adequately diagnostic focused cardiac ultrasounds, lung and pleural ultrasounds, and gastric volume/content assessments.
Prazo: From time of randomization to the time of interpretation of the last POCUS scan, assessed up to 2 weeks from randomization.
An adequately diagnostic focused cardiac ultrasound will be defined as a scan having two or more views showing at least 3 cardiac chambers with diagnostic quality. An adequately diagnostic lung and pleural scan will demonstrate a clear aeration pattern in both hemithoraces with visualization of the diaphragm or a corresponding curtain sign. An adequately diagnostic gastric ultrasound will be done in right lateral decubitus and demonstrate the liver in the near field, a great vessel (aorta or IVC) in the far field, and the stomach antrum deep to the liver in the near to mid-field with visualization of the hypo-echoic muscularis propria. These outcomes will be examined only in participants randomized to the Scan Group.
From time of randomization to the time of interpretation of the last POCUS scan, assessed up to 2 weeks from randomization.
Rates of OR delays for optimization or further work-up.
Prazo: From time of randomization to the time of interpretation of the last POCUS scan, assessed up to 2 weeks from randomization.
Number of delays in the patient's surgery for optimization or further work-up.
From time of randomization to the time of interpretation of the last POCUS scan, assessed up to 2 weeks from randomization.

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Lawson Health Research Institute

Investigadores

  • Investigador principal: Ahmed Hegazy, Assist. Prof, Schulich School of Medicine and Dentistry\Anaesthesia

Publicações e links úteis

A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.

Publicações Gerais

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

4 de abril de 2017

Conclusão Primária (Antecipado)

1 de agosto de 2018

Conclusão do estudo (Antecipado)

30 de setembro de 2018

Datas de inscrição no estudo

Enviado pela primeira vez

28 de abril de 2017

Enviado pela primeira vez que atendeu aos critérios de CQ

3 de maio de 2017

Primeira postagem (Real)

8 de maio de 2017

Atualizações de registro de estudo

Última Atualização Postada (Real)

16 de julho de 2018

Última atualização enviada que atendeu aos critérios de controle de qualidade

12 de julho de 2018

Última verificação

1 de julho de 2018

Mais Informações

Termos relacionados a este estudo

Palavras-chave

Termos MeSH relevantes adicionais

Outros números de identificação do estudo

  • 108613

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

Não

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Ensaios clínicos em Scan

Pesquisar ensaios semelhantes

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

CROs by country

CROs in Suriname

Condições

Doenças Raras

Intervenções de drogas

Suplementos Alimentares

Patrocinador / Colaboradores

Localizações

Se inscrever